Octreotide Hydrochloride News
Octreotide Hydrochloride currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Octreotide Hydrochloride with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Oczyesa is indicated for maintenance treatment in adult patients with acromegaly who have responded to and tolerated treatment with somatostatin analogues.
- Evidence level: L5
- Predicted indications (20):
- vulvar inverted follicular keratosis (99.6%)
- seborrheic keratosis (99.5%)
- nephrotic syndrome ocular anomalies (98.8%)
- Addison disease (98.7%)
- membranoproliferative glomerulonephritis, X-linked (98.7%)
- familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis (98.6%)
- familial idiopathic steroid-resistant nephrotic syndrome with minimal changes (98.6%)
- adrenocortical insufficiency (98.5%)
- primary hypereosinophilic syndrome (98.4%)
- autosomal recessive familial Mediterranean fever (98.3%)
- primary hereditary glaucoma (98.2%)
- secondary hypereosinophilic syndrome (98.1%)
- familial nephrotic syndrome (98.0%)
- open-angle glaucoma (98.0%)
- familial Mediterranean fever, autosomal dominant (97.8%)
- retinal telangiectasia (97.8%)
- renal-hepatic-pancreatic dysplasia (97.7%)
- Smouldering systemic mastocytosis (97.7%)
- gout (97.5%)
- lymphoadenopathic mastocytosis with eosinophilia (97.5%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.